In our study, multivariate analysis showed that PD-L1 and cyclin D1 are factors that increase the odds of tumor invasiveness (OR (95% CI) 2.35 (0.56–9.90) and 1.93 (0.42–8.84), respectively). Here, CD274 is linked to neoplasm.